Biome Australia Issues 125,000 New Shares Under Exemption

Biome Australia Ltd ( (AU:BIO) ) just unveiled an update.

Biome Australia Limited has issued 125,000 fully paid ordinary shares following the exercise of options, as announced on March 4, 2025. This issuance falls under the exemption provided by section 708A(5) of the Corporations Act 2001, allowing the on-sale of these shares without disclosure. The company confirms compliance with relevant sections of the Act and assures that no critical information has been omitted that would affect investors’ assessments. This move is part of Biome Australia’s ongoing efforts to enhance its market presence and operational capabilities.

More about Biome Australia Ltd

Biome Australia Limited is a company that develops, licenses, commercializes, and markets innovative, evidence-based live biotherapeutics (probiotics) and complementary medicines. Founded in 2018 and based in Australia, it partners with leading organizations in microbiome research to produce unique probiotic products. These products, marketed under the brand Activated Probiotics, are designed to improve health outcomes and quality of life, addressing issues like low mood, sleep, bone health, and more. The company focuses on practitioner-only distribution to educate health professionals about the systemic health effects of gut microbiota.

YTD Price Performance: -5.08%

Average Trading Volume: 501,488

Technical Sentiment Consensus Rating: Sell

For detailed information about BIO stock, go to TipRanks’ Stock Analysis page.